Dhaval Desai

Company: IVERIC Bio

Job title: Senior Vice-President & Chief Development Officer

Seminars:

Panel Discussion & Presentation: The Future Landscape of Dry-AMD Therapies 3:30 pm

Further analysis of the treatment landscape for Dry-AMD/GA – What’s on the horizon? Examine patient treatment journey with the emerging new treatment landscape Examine how clinicians/developers can support and deal with treatment burden Explore clinical trial development and the continued impact of the pandemic on on-going clinical trialsRead more

day: Day Two

Spotlight on Zimura – A C5 Inhibitor for GA 9:30 am

Examine Zimura, a high-affinity, high-specificity pegylated RNA aptamer that binds human C5 Learn how prespecified primary efficacy endpoint was achieved for reduction in geographic atrophy (GA) growth rate vs. sham @ 12 months Explore how Zimura was well tolerated over 18 monthsRead more

day: Day One